Examining frailty and quality of life in elderly ICU patients over time
Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients
This study is trying to see how surviving an ICU stay affects the health and quality of life of older patients over a year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | University Hospital of North Norway Academic / other |
| Locations | 5 sites (Lørenskog, Nordbyhagen and 4 other locations) |
| Trial ID | NCT06012942 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess changes in the critical frailty scale (CFS) and health-related quality of life (EQ-5D-5L) among elderly patients who have survived intensive care unit (ICU) treatment. It will identify predictors related to ICU treatment that influence these changes over a one-year follow-up period. Data will be collected through patient interviews and medical records, focusing on demographic information, treatment intensity, and outcomes. The study is coordinated from the University Hospital of North Norway and involves multiple centers across Norway.
Who should consider this trial
Good fit: Ideal candidates are elderly patients aged 65 and older who have undergone at least 24 hours of mechanical ventilation.
Not a fit: Patients who are readmitted to the hospital or unable to provide valid assessments due to social or language barriers may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into improving the long-term care and quality of life for elderly ICU survivors.
How similar studies have performed: Other studies have explored frailty in ICU patients, but this specific long-term follow-up approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>= 65 years * ≥ 24 hours mechanical ventilation * Written informed consent from patient or next of kin Exclusion Criteria: * Readmission of patient included in the study * Not possible to obtain a valid CFS or and EQ-5D-5L at admission or follow-up of CFS because of social context or language.
Where this trial is running
Lørenskog, Nordbyhagen and 4 other locations
- Akershus University hospital, General Intensive care department — Lørenskog, Nordbyhagen, Norway (Recruiting)
- Haukeland University hospital, General Intensive care unit — Bergen, Norway (Recruiting)
- Nordlandssykehuset Bodø, Intensivavdelingen — Bodø, Norway (Recruiting)
- University Hospital of North Norway — Tromsø, Norway (Recruiting)
- Trondheim University hospital, General Intensive care department — Trondheim, Norway (Recruiting)
Study contacts
- Principal investigator: Shirin K Frisvold, MD/PhD — University Hospital of North Norway
- Study coordinator: Bjørn A Kroken, MD
- Email: bjorn.anders.kroken@unn.no
- Phone: 77669863
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.